Diffuse fatty liver disease: From diagnosis to quantification

Abdomen and Thoracic Imaging: An Engineering and Clinical Perspective

Volumn , Issue , 2014, Pages 99-122

  Curvo Semedo, Luís ^a,b   Andrade, Daniel Ramos ^a   Ruivo, Catarina ^a   Paulino, Cláudia ^a   Caseiro Alves, Filipe ^a,b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASES; MAGNETIC RESONANCE IMAGING;

FATTY LIVER; FATTY LIVER DISEASE; GOLD STANDARDS; IMAGING METHOD; LIVER BIOPSIES; LIVER STEATOSIS; NON-INVASIVE IMAGING METHODS; SAMPLING ERRORS;

DIAGNOSIS;

EID: 84955624310     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-8498-1_4     Document Type: Chapter

References (84)

1. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C (2006) Prevalence of fatty liver in children and adolescents. Pediatrics 118:1388–1393
2. Angulo P (2007) Obesity and nonalcoholic fatty liver disease. Nutr Rev 65:S57–S63
3. Adams LA, Lymp JF, St Sauver J et al (2005) The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129:113–121
4. Stefan N, Kantartzis K, Haring HU (2008) Causes and metabolic consequences of fatty liver. Endocr Rev 29:939–960
5. Stefan N, Kantartzis K, Machann J et al (2008) Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609–1616
6. Kotronen A, Westerbacka J, Bergholm R, Pietilainen KH, Yki-Jarvinen H (2007) Liver fat in the metabolic syndrome. J Clin Endocrinol Metab 92:3490–3497
7. Roden M (2006) Mechanisms of disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2:335–348
8. Stefan N, Hennige AM, Staiger H et al (2006) Alpha2-Heremans-Schmid glycoprotein/fetuin- A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853–857
9. Reinehr T, Roth CL (2008) Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 93:4479–4485
10. Farrell GC, Larter CZ (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99–S112
11. Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321
12. Lefkowitch JH (2005) Morphology of alcoholic liver disease. Clin Liver Dis 9:37–53
13. Reuben A (2007) Alcohol and the liver. Curr Opin Gastroenterol 23:283–291
14. Reuben A (2008) Alcohol and the liver. Curr Opin Gastroenterol 24:328–338
15. Wanless IR, Shiota K (2004) The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 24:99–106
16. Valls C, Iannacconne R, Alba E et al (2006) Fat in the liver: diagnosis and characterization. Eur Radiol 16:2292–2308
17. Oleszczuk A, Spannbauer M, Tannapfel A et al (2007) Regenerative capacity differs between micro and macrovesicular hepatic steatosis. Exp Toxicol Pathol 59:205–213
18. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB (2006) Fatty liver: imaging patterns and pitfalls. Radiographics 26:1637–1653
19. Fishbein M, Castro F, Cheruku S et al (2005) Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 39:619–625
20. Chalasani N, Wilson L, Kleiner DE, Cummings OW, Brunt EM, Unalp A (2008) Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. J Hepatol 48:829–834
21. Strassburg CP, Manns MP (2006) Approaches to liver biopsy techniques—revisited. Semin Liver Dis 26:318–327
22. Minervini MI, Ruppert K, Fontes P et al (2009) Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J Hepatol 50:501–510
23. Nagai S, Fujimoto Y, Kamei H, Nakamura T, Kiuchi T (2009) Mild hepatic macrovesicular steatosis may be a risk factor for hyperbilirubinaemia in living liver donors following right hepatectomy. Br J Surg 96:437–444
24. Limanond P, Raman SS, Lassman C et al (2004) Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230:276–280
25. Vetelainen R, van Vliet A, Gouma DJ, van Gulik TM (2007) Steatosis as a risk factor in liver surgery. Ann Surg 245:20–30
26. Cowin GJ, Jonsson JR, Bauer JD et al (2008) Magnetic resonance imaging and spectroscopy for monitoring liver steatosis. J Magn Reson Imaging 28:937–945
27. Wieckowska A, McCullough AJ, Feldstein AE (2007) Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46:582–589
28. Karcaaltincaba M, Akhan O (2007) Imaging of hepatic steatosis and fatty sparing. Eur J Radiol 61(1):33–43
29. Perez NE, Siddiqui FA, Mutchnick MG et al (2007) Ultrasound diagnosis of fatty liver in patients with chronic liver disease: a retrospective observational study. J Clin Gastroenterol 41:624–629
30. Schwenzer NF, Springer F, Schraml C, Stefan N, Machann J, Schick F (2009) Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol 51(3):433–445
31. Joseph AE, Saverymuttu SH, Al-Sam S, Cook MG, Maxwell JD (1991) Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43:26–31
32. Mottin CC, Moretto M, Padoin AV et al (2004) The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 14:635–637
33. Lall CG, Aisen AM, Bansal N, Sandrasegaran K (2008) Nonalcoholic fatty liver disease. Am J Roentgenol 190(4):993–1002
34. Shannon A, Alkhouri N, Carter-Kent C et al (2011) Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 53(2):190–195
35. Strauss S, Gavish E, Gottlieb P, Katsnelson L (2007) Interobserver and intraobserver variability in the sonographic assessment of fatty liver. Am J Roentgenol 189:W320–W323
36. Mancini M, Prinster A, Annuzzi G et al (2009) Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with 1H magnetic resonance spectroscopy. Metabolism 58 (12):1724–1730
37. Xia MF, Yan HM, He WY et al (2012) Standardized ultrasound hepatic/renal ratio and hepatic attenuation rate to quantify liver fat content: an improvement method. Obesity (Silver Spring) 20(2):444–452
38. Webb M, Yeshua H, Zelber-Sagi S et al (2009) Diagnostic value of a computerized hepatorenal index for sonographic quantification of liver steatosis. Am J Roentgenol 192 (4):909–914
39. Graif M, Yanuka M, Baraz M et al (2000) Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. Invest Radiol 35:319–324
40. Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, Sahani DV (2009) Imaging-based quantification of hepatic fat: methods and clinical applications. Radiographics 29(5):1253–1277
41. Lee SW, Park SH, Kim KW et al (2007) Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 244(2):479–485
42. Kodama Y, Ng CS, Wu TT et al (2007) Comparison of CT methods for determining the fat content of the liver. Am J Roentgenol 188(5):1307–1312
43. Mazhar SM, Shiehmorteza M, Sirlin CB (2009) Noninvasive assessment of hepatic steatosis. Clin Gastroenterol Hepatol 7(2):135–140
44. Park SH, Kim PN, Kim KW et al (2006) Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239:105–112
45. Shores NJ, Link K, Fernandez A et al (2011) Non-contrasted computed tomography for the accurate measurement of liver steatosis in obese patients. Dig Dis Sci 56(7):2145–2151
46. Piekarski J, Goldberg HI, Royal SA, Axel L, Moss AA (1980) Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. Radiology 137:727–729
47. Johnston RJ, Stamm ER, Lewin JM, Hendrick RE, Archer PG (1998) Diagnosis of fatty infiltration of the liver on contrast-enhanced CT: limitations of liver-minus-spleen attenuation difference measurements. Abdom Imaging 23(4):409–415
48. Jacobs JE, Birnbaum BA, Shapiro MA et al (1998) Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. Am J Roentgenol 171:659–664
49. Panicek DM, Giess CS, Schwartz LH (1997) Qualitative assessment of liver for fatty infiltration on contrast-enhanced CT: is muscle a better standard of reference than spleen? J Comput Assist Tomogr 21:699–705
50. Flohr TG, McCollough CH, Bruder H et al (2006) First performance evaluation of a dualsource CT (DSCT) system. Eur Radiol 16:256–268
51. Wang B, Gao Z, Zou Q, Li L (2003) Quantitative diagnosis of fatty liver with dual-energy CT. An experimental study in rabbits. Acta Radiol 44:92–97
52. Raptopoulos V, Karellas A, Bernstein J, Reale FR, Constantinou C, Zawacki JK (1991) Value of dual-energy CT in differentiating focal fatty infiltration of the liver from low-density masses. Am J Roentgenol 157:721–725
53. Mendler MH, Bouillet P, Le Sidaner A et al (1998) Dual-energy CT in the diagnosis and quantification of fatty liver: limited clinical value in comparison to ultrasound scan and singleenergy CT, with special reference to iron overload. J Hepatol 28:785–794
54. Birnbaum BA, Hindman N, Lee J, Babb JS (2007) Multi-detector row CT attenuation measurements: assessment of intra- and interscanner variability with an anthropomorphic body CT phantom. Radiology 242:109–119
55. Cassidy FH, Yokoo T, Aganovic L et al (2009) Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics 29(1):231–260
56. Park HW, Kim YH, Cho ZH (1988) Fast gradient-echo chemical-shift imaging. Magn Reson Med 7:340–345
57. Chen Q, Stock KW, Prasad PV, Hatabu H (1999) Fast magnetic resonance imaging techniques. Eur J Radiol 29:90–100
58. Hussain HK, Chenevert TL, Londy FJ et al (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology 237:1048–1055
59. Alustiza JM, Castiella A (2008) Liver fat and iron at in-phase and opposed-phase MR imaging. Radiology 246:641
60. Westphalen AC, Qayyum A, Yeh BM et al (2007) Liver fat: effect of hepatic iron deposition on evaluation with opposed-phase MR imaging. Radiology 242:450–455
61. Fishbein MH, Gardner KG, Potter CJ, Schmalbrock P, Smith MA (1997) Introduction of fast MR imaging in the assessment of hepatic steatosis. Magn Reson Imaging 15:287–293
62. Levenson H, Greensite F, Hoefs J et al (1991) Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. Am J Roentgenol 156:307–312
63. Mitchell DG, Kim I, Chang TS et al (1991) Fatty liver: chemical shift phase-difference and suppression magnetic resonance imaging techniques in animals, phantoms, and humans. Invest Radiol 26:1041–1052
64. Borrello JA, Chenevert TL, Meyer CR, Aisen AM, Glazer GM (1987) Chemical shift-based true water and fat images: regional phase correction of modified spin-echo MR images. Radiology 164:531–537
65. Glover GH, Schneider E (1991) Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med 18:371–383
66. Glover GH (1991) Multipoint Dixon technique for water and fat proton and susceptibility imaging. J Magn Reson Imaging 1:521–530
67. Lodes CC, Felmlee JP, Ehman RL et al (1989) Proton MR chemical shift imaging using double and triple phase contrast acquisition methods. J Comput Assist Tomogr 13:855–861
68. Rybicki FJ, Chung T, Reid J, Jaramillo D, Mulkern RV, Ma J (2001) Fast three-point Dixon MR imaging using low-resolution images for phase correction: a comparison with chemical shift selective fat suppression for pediatric musculoskeletal imaging. Am J Roentgenol 177:1019–1023
69. Szumowski J, Coshow WR, Li F, Quinn SF (1994) Phase unwrapping in the three-point Dixon method for fat suppression MR imaging. Radiology 192:555–561
70. Szumowski J, Coshow W, Li F, Coombs B, Quinn SF (1995) Double-echo three-point-Dixon method for fat suppression MRI. Magn Reson Med 34:120–124
71. Yeung HN, Kormos DW (1986) Separation of true fat and water images by correcting magnetic field inhomogeneity in situ. Radiology 159:783–786
72. Reeder SB, Pineda AR, Wen Z et al (2005) Iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL): application with fast spin-echo imaging. Magn Reson Med 54:636–644
73. Reeder SB, McKenzie CA, Pineda AR et al (2007) Water–fat separation with IDEAL gradientecho imaging. J Magn Reson Imaging 25:644–652
74. Mehta SR, Thomas EL, Bell JD, Johnston DG, Taylor-Robinson SD (2008) Non-invasive means of measuring hepatic fat content. World J Gastroenterol 14:3476–3483
75. Guiu B, Petit JM, Loffroy R et al (2009) Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 250:95–102
76. Mitchell DG, Stolpen AH, Siegelman ES, Bolinger L, Outwater EK (1996) Fatty tissue on opposed-phase MR images: paradoxical suppression of signal intensity by paramagnetic contrast agents. Radiology 198:351–357
77. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV (2005) Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques—initial experience. Radiology 237:507–511
78. Cotler SJ, Guzman G, Layden-Almer J, Mazzone T, Layden TJ, Zhou XJ (2007) Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging 25:743–748
79. Bottomley PA (1987) Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 508:333–348
80. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hanicke W, Sauter R (1989) Localized highresolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 9:79–93
81. Machann J, Stefan N, Schick F (2008) 1H MR spectroscopy of skeletal muscle, liver and bone marrow. Eur J Radiol 67:275–284
82. Machann J, Thamer C, Schnoedt B et al (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat-selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55:913–917
83. Thomas EL, Hamilton G, Patel N et al (2005) Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut 54:122–127
84. Szczepaniak LS, Nurenberg P, Leonard D et al (2005) Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 288:E462–E468